Related references
Note: Only part of the references are listed.The influence of 18flourodeoxyglucose positron emission tomography on the management of gastroesophageal junction carcinoma
Jason W. Smith et al.
AMERICAN JOURNAL OF SURGERY (2009)
Pathologic Response to Preoperative Therapy: Does It Mean What We Think It Means?
John C. Mansour et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Influence of the Baseline 18F-Fluoro-2-deoxy-D-glucose Positron Emission Tomography Results on Survival and Pathologic Response in Patients With Gastroesophageal Cancer Undergoing Chemoradiation
Heta Javeri et al.
CANCER (2009)
Mean and maximum standardized uptake values in [18F]FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapy
Matthias Schmidt et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Change in maximum standardized uptake value on repeat positron emission tomography after chemoradiotherapy in patients with esophageal cancer identifies complete responders
Robert J. Cerfolio et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2009)
Metabolic Tumor Width Parameters as Determined on PET/CT Predict Disease-free Survival and Treatment Response in Squamous Cell Carcinoma of the Esophagus
Johannes B. Roedl et al.
MOLECULAR IMAGING AND BIOLOGY (2009)
Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography
Johannes B. Roedl et al.
ANNALS OF THORACIC SURGERY (2008)
Positron emission tomography and pathological evidence of response to neoadjuvant therapy in adenocarcinoma of the esophagus
B. M. Smithers et al.
DISEASES OF THE ESOPHAGUS (2008)
Are patients with esophageal cancer. who become PET negative after neoadjuvant chemoradiation free of cancer?
James M. McLoughlin et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2008)
Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma
Ichirou Higuchi et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2008)
Adenocarcinomas of the esophagus: Response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation
Johannes B. Roedl et al.
RADIOTHERAPY AND ONCOLOGY (2008)
Use of 18F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma
Tomoki Makino et al.
SURGERY (2008)
Semiautomatic volume of interest drawing for 18F-FDG image analysis -: method and preliminary results
A. J. Green et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction
Hinrich A. Wieder et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma
Andre A. Konski et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction:: The MUNICON phase II trial
Florian Lordick et al.
LANCET ONCOLOGY (2007)
Positron emission tomographic scanning predicts survival after induction chemotherapy for esophageal carcinoma
Jeffrey L. Port et al.
ANNALS OF THORACIC SURGERY (2007)
FDG-PET/CT tumor segmentation-derived indices of metabolic activity to assess response to Neoadjuvant therapy and progression-free survival in esophageal cancer -: Correlation with histopothology results
Marcelo Mamede et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2007)
Value of complete metabolic response by 18F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy
Min Kyoung Kim et al.
EUROPEAN JOURNAL OF CANCER (2007)
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis
Val Gebski et al.
LANCET ONCOLOGY (2007)
Detection of interval distant metastases - Clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy
John F. Bruzzi et al.
CANCER (2007)
18FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response
C. M. Gillham et al.
BRITISH JOURNAL OF CANCER (2006)
Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction
Katja Ott et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
FDG-PET status following chemoradiotherapy provides high management impact and powerful prognostic stratification in oesophageal cancer
Cuong P. Duong et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: A confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging
Jeremy J. Erasmus et al.
JOURNAL OF THORACIC ONCOLOGY (2006)
Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer
EA Levine et al.
ANNALS OF SURGERY (2006)
Monitoring of response to pre-operative chemoradiation in combination with hyperthermia in oesophageal cancer by FDG-PET
Marinke Westerterp et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2006)
FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer
SY Song et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy - Systematic review
M Westerterp et al.
RADIOLOGY (2005)
The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy
RJ Cerfolio et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2005)
Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation
LR Chirieac et al.
CANCER (2005)
Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment
HA Wieder et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
2-fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma
SG Swisher et al.
CANCER (2004)
Effects of neoadjuvant radio-chemotherapy on 18F-FDG-PET in esophageal carcinoma
I Brink et al.
EJSO (2004)
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer
SG Swisher et al.
ANNALS OF THORACIC SURGERY (2004)
Medical progress - Esophageal cancer
PC Enzinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Receiver operating characteristic curves and their use in radiology
NA Obuchowski
RADIOLOGY (2003)
Tumor response to induction chemoradiation: influence on survival after esophagectomy
JS Donington et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2003)
Whole body 18FDG-PET and the response of esophageal cancer to induction therapy:: Results of a prospective trial
RJ Downey et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Towards complete and,accurate reporting of studies of diagnostic accuracy: the STARD initiative
PM Bossuyt et al.
BRITISH MEDICAL JOURNAL (2003)
The diagnostic odds ratio: a single indicator of test performance
AS Glas et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2003)
Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer
H Kato et al.
AMERICAN JOURNAL OF SURGERY (2002)
Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer
P Flamen et al.
ANNALS OF ONCOLOGY (2002)
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging
WA Weber et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
